Scientific Reference

SS-31 (Elamipretide)

Evidence profile: Human Phase 3 evidence

SS-31 (elamipretide) is a small aromatic-cationic tetrapeptide that localises to the inner mitochondrial membrane. Rather than scavenging reactive oxygen species diffusely as conventional antioxidants do, it binds cardiolipin — a phospholipid required for the structural integrity of the electron transport chain — and the published literature describes this targeted interaction in the context of mitochondrial function. SS-31 is not an approved medicine in the United Kingdom. Supplied strictly as a research compound for laboratory use.

Published Research

  • Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER

    Thompson WR et al. · Genetics in medicine : official journal of the American College of Medical Genetics · 2024 · Clinical

    PMID 38602181 — View on PubMed
  • Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial

    Karaa A et al. · Neurology · 2023 · Clinical

    PMID 37268435 — View on PubMed